Acumen Pharmaceuticals Inc (ABOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -35,874 | -22,917 | -11,307 | -42,856 | -29,990 |
| Depreciation Amortization | -1,199 | -529 | -282 | 656 | 695 |
| Accounts payable and accrued liabilities | -278 | 384 | -878 | 552 | 996 |
| Other Working Capital | -2,188 | -1,310 | 24 | 3,986 | 3,172 |
| Other Operating Activity | 4,789 | 2,527 | 2,268 | 2,509 | 1,177 |
| Operating Cash Flow | $-34,750 | $-21,845 | $-10,175 | $-35,153 | $-23,950 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -122,860 | -30,863 | -41,927 | 39,346 | 59,731 |
| PPE Investments | -4 | N/A | N/A | -161 | -126 |
| Investing Cash Flow | $-122,864 | $-30,863 | $-41,927 | $39,185 | $59,605 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 122,619 | N/A | N/A | 3,907 | 19 |
| Other Financing Activity | 0 | -145 | 0 | 0 | -296 |
| Financing Cash Flow | $122,619 | $-145 | $0 | $3,907 | $-277 |
| Beginning Cash Position | 130,101 | 130,101 | 130,101 | 122,162 | 122,162 |
| End Cash Position | 95,106 | 77,248 | 77,999 | 130,101 | 157,540 |
| Net Cash Flow | $-34,995 | $-52,853 | $-52,102 | $7,939 | $35,378 |
| Free Cash Flow | |||||
| Operating Cash Flow | -34,750 | -21,845 | -10,175 | -35,153 | -23,950 |
| Capital Expenditure | -7 | N/A | N/A | -161 | -126 |
| Free Cash Flow | -34,757 | -21,845 | -10,175 | -35,314 | -24,076 |